Autoantibodies against angiotensin-converting enzyme 2 (ACE2) after COVID-19 infection or vaccination
Description
Autoantibodies against angiotensin-converting enzyme 2 (ACE2) are frequently reported in patients during coronavirus disease 2019 (COVID-19) with evidence for a pathogenic role in severe infection. However, little is known of the prevalence or
